Product image of Haloperidol Krka (Haloperidol) supplied by GNH India

Haloperidol Krka

Active Ingredient:
Haloperidol
Origin:
EU

Haloperidol Krka (Haloperidol)

Haloperidol Krka is a prescription oral medication that contains the antipsychotic active ingredient haloperidol. It is manufactured by the Krka pharmaceutical company and is marketed within the European Union. The product is supplied as an oral dosage form, though the exact strength is not specified in the available information. Haloperidol Krka is classified as a butyrophenone antipsychotic and is available only with a prescription in many clinical settings.

Manufacturer / TM Owner

Krka-Farma D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

Haloperidol Krka is indicated for several psychiatric conditions where dopamine blockade is therapeutic.

  • Schizophrenia (including maintenance treatment)
  • Acute psychotic episodes
  • Manic episodes of bipolar disorder
  • Severe agitation requiring rapid control
  • Tourette syndrome (symptom management)

Side Effects

Side effects of haloperidol may vary in frequency and severity; they are typically categorized as common or serious.

Common

  • Drowsiness or sedation
  • Extrapyramidal symptoms such as tremor or rigidity
  • Dry mouth
  • Constipation
  • Blurred vision

Serious

  • Tardive dyskinesia (involuntary movements)
  • Neuroleptic malignant syndrome (fever, muscle rigidity)
  • Cardiac arrhythmias (QT prolongation)

Precautions & Warnings

When prescribing Haloperidol Krka, clinicians consider several precautions to minimize risks and ensure safe use.

  • Assess cardiovascular status, especially for QT prolongation risk
  • Evaluate for history of movement disorders or tardive dyskinesia
  • Use the lowest effective dose for the shortest duration needed
  • Monitor for signs of neuroleptic malignant syndrome
  • Caution in patients with hepatic or renal impairment
  • Avoid abrupt discontinuation to reduce withdrawal or relapse

Avoid Interactions

Haloperidol can interact with other medicines, influencing its effectiveness or safety profile.

Avoid

  • Other dopamine antagonists or antipsychotics
  • Medications that prolong QT interval (e.g., certain antiarrhythmics)
  • Strong CYP3A4 inhibitors (e.g., ketoconazole)

Use with caution

  • CYP3A4 inducers (e.g., carbamazepine)
  • CNS depressants such as benzodiazepines or opioids
  • Anticholinergic agents (may mask extrapyramidal symptoms)

Frequently Asked Questions

Haloperidol Krka is a prescription oral medication that contains the antipsychotic drug haloperidol, a dopamine D2 receptor antagonist.

It is commonly prescribed for schizophrenia, acute psychotic episodes, manic phases of bipolar disorder, severe agitation, and symptom control in Tourette syndrome.

Haloperidol blocks postsynaptic dopamine D2 receptors, reducing dopaminergic neurotransmission that is thought to contribute to psychotic symptoms.

No, Haloperidol Krka is a prescription‑only medication and must be prescribed by a qualified healthcare professional.

Common side effects include drowsiness, extrapyramidal symptoms such as tremor or rigidity, dry mouth, constipation, and blurred vision.

Serious reactions can include tardive dyskinesia, neuroleptic malignant syndrome, and cardiac arrhythmias related to QT interval prolongation.

Patients with risk factors for QT prolongation or existing heart conditions may require ECG monitoring, especially at higher doses.

The pregnancy safety category for Haloperidol Krka is not specified in the provided data; clinicians should weigh potential benefits against risks.

Medications that also prolong the QT interval, strong CYP3A4 inhibitors, and other dopamine antagonists should generally be avoided.

Abrupt discontinuation is discouraged; tapering the dose under medical supervision helps reduce the risk of withdrawal symptoms or relapse.

Dose adjustments may be necessary for patients with significant hepatic or renal impairment; clinicians should assess individual metabolic capacity.

Haloperidol Krka is classified under ATC code N05AD01, which corresponds to butyrophenone antipsychotics.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Haloperidol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT